HCA vs REPL
HCA Holdings Inc (HCA) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
REPL does not have a complete income-statement cache yet.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. REPL currently screens at market cap $825.7M.
Not investment advice. Open the HCA and REPL stock pages for the full models.
Not investment advice.